Jason Chiang1, Xiaoyu Li1, Hongjian Jin2, Gang Wu1,2, Tong Lin3, David W Ellison1. 1. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 2. Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 3. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract
AIMS: Desmoplastic infantile astrocytomas and gangliogliomas (DIA/DIGs) are rare brain tumours of infancy. A distinctive feature of their histopathology is a combination of low-grade and high-grade features. Most DIA/DIGs can be surgically resected and have a good prognosis. However, high-grade features often dominate recurrent tumours, some of which have a poor outcome. In this study, we test the hypothesis that low-grade and high-grade areas in DIA/DIGs have distinct molecular characteristics. METHODS: Tissue samples from microdissected low-grade and high-grade areas in 12 DIA/DIGs were analysed by DNA methylation profiling, whole exome sequencing, RNA sequencing and immunohistochemistry to search for potential differences at multiple molecular levels. RESULTS: Copy number variants among tumours and between the two morphologically distinct areas were infrequent. No recurrent genetic alterations were identified across the tumour series, and high-grade areas did not have additional genetic alterations to explain their distinct morphology or biological behaviour. However, high-grade areas showed relative hypomethylation in genes downstream of the transcription factors SOX9 and LEF1 and evidence of a core SOX9 transcription network alongside activation of the BMP, WNT and MAPK signalling pathways. CONCLUSIONS: This study contributes to our knowledge of molecular genetic alterations in DIA/DIGs, uncovers molecular differences between the two distinct cell populations in these tumours and suggests potential therapeutic targets among the more proliferative cell population in DIA/DIGs.
AIMS: Desmoplastic infantile astrocytomas and gangliogliomas (DIA/DIGs) are rare brain tumours of infancy. A distinctive feature of their histopathology is a combination of low-grade and high-grade features. Most DIA/DIGs can be surgically resected and have a good prognosis. However, high-grade features often dominate recurrent tumours, some of which have a poor outcome. In this study, we test the hypothesis that low-grade and high-grade areas in DIA/DIGs have distinct molecular characteristics. METHODS: Tissue samples from microdissected low-grade and high-grade areas in 12 DIA/DIGs were analysed by DNA methylation profiling, whole exome sequencing, RNA sequencing and immunohistochemistry to search for potential differences at multiple molecular levels. RESULTS: Copy number variants among tumours and between the two morphologically distinct areas were infrequent. No recurrent genetic alterations were identified across the tumour series, and high-grade areas did not have additional genetic alterations to explain their distinct morphology or biological behaviour. However, high-grade areas showed relative hypomethylation in genes downstream of the transcription factors SOX9 and LEF1 and evidence of a core SOX9 transcription network alongside activation of the BMP, WNT and MAPK signalling pathways. CONCLUSIONS: This study contributes to our knowledge of molecular genetic alterations in DIA/DIGs, uncovers molecular differences between the two distinct cell populations in these tumours and suggests potential therapeutic targets among the more proliferative cell population in DIA/DIGs.
Authors: Hanna Sabelström; Rebecca Petri; Ksenya Shchors; Rahul Jandial; Christin Schmidt; Rohit Sacheva; Selma Masic; Edith Yuan; Trenten Fenster; Michael Martinez; Supna Saxena; Theodore P Nicolaides; Shirin Ilkhanizadeh; Mitchel S Berger; Evan Y Snyder; William A Weiss; Johan Jakobsson; Anders I Persson Journal: Cell Rep Date: 2019-08-20 Impact factor: 9.423
Authors: Jason Chiang; Xiaoyu Li; Anthony P Y Liu; Ibrahim Qaddoumi; Sahaja Acharya; David W Ellison Journal: Acta Neuropathol Date: 2019-12-10 Impact factor: 17.088
Authors: Melissa M Blessing; Patrick R Blackburn; Chandra Krishnan; Virginia L Harrod; Emily G Barr Fritcher; Christopher D Zysk; Rory A Jackson; Dragana Milosevic; Asha A Nair; Jaime I Davila; Jessica R Balcom; Robert B Jenkins; Kevin C Halling; Benjamin R Kipp; Amulya A Nageswara Rao; Nadia N Laack; David J Daniels; William R Macon; Cristiane M Ida Journal: J Neuropathol Exp Neurol Date: 2019-11-01 Impact factor: 3.685
Authors: Kathryn R Taylor; Alan Mackay; Nathalène Truffaux; Yaron Butterfield; Olena Morozova; Cathy Philippe; David Castel; Catherine S Grasso; Maria Vinci; Diana Carvalho; Angel M Carcaboso; Carmen de Torres; Ofelia Cruz; Jaume Mora; Natacha Entz-Werle; Wendy J Ingram; Michelle Monje; Darren Hargrave; Alex N Bullock; Stéphanie Puget; Stephen Yip; Chris Jones; Jacques Grill Journal: Nat Genet Date: 2014-04-06 Impact factor: 38.330
Authors: Jason Chiang; Alexander K Diaz; Lydia Makepeace; Xiaoyu Li; Yuanyuan Han; Yimei Li; Paul Klimo; Frederick A Boop; Suzanne J Baker; Amar Gajjar; Thomas E Merchant; David W Ellison; Alberto Broniscer; Zoltan Patay; Christopher L Tinkle Journal: Acta Neuropathol Commun Date: 2020-04-23 Impact factor: 7.578
Authors: John G Tate; Sally Bamford; Harry C Jubb; Zbyslaw Sondka; David M Beare; Nidhi Bindal; Harry Boutselakis; Charlotte G Cole; Celestino Creatore; Elisabeth Dawson; Peter Fish; Bhavana Harsha; Charlie Hathaway; Steve C Jupe; Chai Yin Kok; Kate Noble; Laura Ponting; Christopher C Ramshaw; Claire E Rye; Helen E Speedy; Ray Stefancsik; Sam L Thompson; Shicai Wang; Sari Ward; Peter J Campbell; Simon A Forbes Journal: Nucleic Acids Res Date: 2019-01-08 Impact factor: 16.971